Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL122808 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL1396195 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL1076271 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL156385 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL1804580 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL734680 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL232957 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL736397 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL2020039 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL14760076 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250333578-A1 | COMPOSITION MADE FROM POLY(ARYLENE-ETHER-KETONE) (PAEK) WHICH IS STABLE IN THE MOLTEN STATE AND METHOD FOR STABILIZING SUCH A COMPOSITION | ARKEMA FRANCE (FR) | 2025-10-30 | — | — | US | claimed |
| CN-113088062-B | Method for stabilizing a composition made of poly (arylene-ether-ketone) (PAEK) | 阿科玛法国公司 | 2024-07-02 | — | — | CN | claimed |
| EP-3325536-B1 | PROCESS FOR STABILIZING A COMPOSITION OF POLYARYL-ETHER-KETONE (PAEK) | ARKEMA FRANCE (FR) | 2024-06-26 | — | — | EP | claimed |
| CN-116421924-B | Method for degrading tributyl phosphate and recovering phosphorus element by using alkali-assisted trimanganese tetroxide | 四川大学 | 2024-06-14 | — | — | CN | claimed |
| CN-107250318-B | Super concentrate additive solution compositions | 布拉斯通产品公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116421924-A | Method for degrading tributyl phosphate and recovering phosphorus element by using alkali-assisted trimanganese tetroxide | 四川大学 | 2023-07-14 | — | — | CN | claimed |
| US-11214723-B2 | Super concentrate additive solution composition | PRESTONE PRODUCTS CORPORATION (US) | 2022-01-04 | — | — | US | claimed |
| EP-3690001-B1 | SUPER CONCENTRATE ADDITIVE SOLUTION COMPOSITION | PRESTONE PRODUCTS CORP (US) | 2021-12-15 | — | — | EP | claimed |
| CN-113088062-A | Method for stabilizing compositions made from poly (arylene-ether-ketones) (PAEKs) | 阿科玛法国公司 | 2021-07-09 | — | — | CN | claimed |
| US-20210171732-A1 | COMPOSITION MADE FROM POLY(ARYLENE-ETHER-KETONE) (PAEK) WHICH IS STABLE IN THE MOLTEN STATE AND METHOD FOR STABILIZING SUCH A COMPOSITION | ARKEMA FRANCE (FR) | 2021-06-10 | — | — | US | claimed |
| CN-112678211-A | Filling machine with sealing mechanism for producing trisodium phosphate octahydrate and using method | 云南宣威磷电有限责任公司 | 2021-04-20 | — | — | CN | claimed |
| EP-3690001-A1 | SUPER CONCENTRATE ADDITIVE SOLUTION COMPOSITION | Prestone Products Corporation (US) | 2020-08-05 | — | — | EP | claimed |
| EP-3265535-B1 | SUPER CONCENTRATE ADDITIVE SOLUTION COMPOSITION | PRESTONE PRODUCTS CORP (US) | 2020-02-12 | — | — | EP | claimed |
| US-20180208741-A1 | METHOD FOR STABILISING A COMPOSITION MADE FROM POLY(ARYLENE-ETHER-KETONE) (PAEK) | ARKEMA FRANCE (FR) | 2018-07-26 | — | — | US | claimed |
| EP-3265535-A1 | SUPER CONCENTRATE ADDITIVE SOLUTION COMPOSITION | Prestone Products Corporation (US) | 2018-01-10 | — | — | EP | claimed |
| US-20160257868-A1 | SUPER CONCENTRATE ADDITIVE SOLUTION COMPOSITION | GOLDMAN SACHS MIDDLE MARKET LENDING CORP. II | 2016-09-08 | — | — | US | claimed |
| EP-1855693-B1 | AZITHROMYCIN POWDER FOR ORAL SUSPENSION COMPOSITIONS | TEVA PHARMA (IL) | 2009-07-29 | — | — | EP | claimed |
| EP-1855693-A1 | AZITHROMYCIN POWDER FOR ORAL SUSPENSION COMPOSITIONS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-11-21 | — | — | EP | claimed |
| WO-2006096182-A1 | AZITHROMYCIN POWDER FOR ORAL SUSPENSION COMPOSITIONS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2006-09-14 | — | — | WO | claimed |
| US-20060198895-A1 | Azithromycin powder for oral suspension compositions | TEVA PHARMACEUTICALS USA, LTD. | 2006-09-07 | — | — | US | claimed |